Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Novonesis (NVZMY) Stock Price & Analysis

NVZMY Stock Chart & Stats

$69.10$0.06(0.09%)
At close: 11:15 AM EST
$62.5$65$67.5$7013 Jul27 Jul10 Aug24 Aug4 Sep16 Sep9 Oct
Day’s Range
$69.01 - $69.01
52-Week Range
$52.70 - $72.18
Previous Close
$69.50
Volume
N/A
Average Volume (3M)
811
Market Cap
$32.19B
Enterprise Value
$32.59B
Total Cash (Recent Filing)
$313.47M
Total Debt (Recent Filing)
$3.07B
Price to Earnings (P/E)
44.2
Beta
0.07
Next Earnings
Nov 05, 2026 (Est.)
EPS Estimate
0.74
Last Dividend Ex-Date
Aug 31, 2026
Dividend Yield
0.23%

Bulls Say, Bears Say

Bulls Say

Organic Growth And Upgraded Guidance

Broad-based organic growth and upgraded full-year guidance indicate sustained customer demand across Novonesis’s biosolutions portfolio. Volume-led expansion, pricing, and sales synergies should support revenue progression while the diversified end-market exposure reduces reliance on a single application area.

Strong And Sustainable Margins

High gross and EBITDA margins reflect the value of proprietary enzymes, cultures, and application expertise in customers’ production processes. Margin expansion also provides resilience and creates internal funding capacity for research, commercial expansion, and manufacturing investments.

Robust Cash Generation

Strong operating cash generation gives Novonesis financial capacity to invest in new production facilities, innovation, and acquisitions while supporting shareholder returns. This cash profile can strengthen execution of the growth strategy and provide flexibility through normal earnings fluctuations.

Bears Say

Inconsistent Bottom-line Profitability

A TTM net loss alongside healthy operating margins indicates that reported earnings are less consistent than the underlying operating performance. Profit volatility can reduce confidence in repeatable earnings conversion and make future returns more sensitive to non-operating or one-time effects.

Volatile Leverage Profile

The sharp change in reported debt-to-equity creates uncertainty about Novonesis’s balance-sheet trajectory and financial flexibility. Although the TTM position is conservative, a repeat of elevated leverage could increase financing sensitivity and constrain capital allocation during weaker operating periods.

Human Health Softness

Slower Human Health growth, including weaker North American dietary-supplement demand, creates a drag on the company’s otherwise broad expansion. Continued softness would limit contribution from this end market and make performance more dependent on stronger execution in other businesses.

Novonesis News

NVZMY FAQ

What was Novonesis’s price range in the past 12 months?
Novonesis lowest stock price was $52.70 and its highest was $72.18 in the past 12 months.
What is Novonesis’s market cap?
Novonesis’s market cap is $32.19B.
When is Novonesis’s upcoming earnings report date?
Novonesis’s next earnings report is estimated for Nov 05, 2026 (not yet confirmed), which is in 3 days.
How were Novonesis’s earnings last quarter?
Novonesis released its earnings results on Aug 19, 2026. The company reported $0.443 earnings per share for the quarter, missing the consensus estimate of $0.626 by -$0.183.
Is Novonesis overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Novonesis pay dividends?
Novonesis pays a Semiannually dividend of $0.056 which represents an annual dividend yield of 0.23%. See more information on Novonesis dividends here
What is Novonesis’s EPS estimate?
Novonesis’s EPS estimate is 0.74.
How many shares outstanding does Novonesis have?
Novonesis has 414,555,050 shares outstanding.
What happened to Novonesis’s price movement after its last earnings report?
Novonesis reported an EPS of $0.443 in its last earnings report, missing expectations of $0.626. Following the earnings report the stock price went up 0.022%.
Which hedge fund is a major shareholder of Novonesis?
Currently, no hedge funds are holding shares in NVZMY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology